Fibrinogen (Factor I) Test: What High and Low Levels Mean

Fibrinogen is a protein made by the liver that helps blood clot and often rises with inflammation or injury. A fibrinogen test measures this protein, and results outside the typical range may need further medical evaluation with a healthcare provider.

Fibrinogen, also called factor I, is a protein made by the liver and released into the bloodstream. It plays a central role in the clotting process: when tissue is injured, fibrinogen is converted into fibrin, which forms the mesh-like structure of a blood clot to stop bleeding. Fibrinogen is also known as an acute-phase reactant, meaning its levels can rise quickly during inflammation, infection, or tissue damage, independent of clotting activity. Because of this dual role, a fibrinogen test can offer clues about both the coagulation system and the body's inflammatory response, which is why it appears in coagulation panels alongside other clotting tests like PT/INR and aPTT.

A fibrinogen test is often part of a coagulation panel ordered when someone has unexplained bleeding, bruising, or a history of blood clots. It may be checked before surgery to assess clotting risk, or alongside PT/INR and aPTT when these results are prolonged, since low fibrinogen can be one cause of abnormal clotting times. Fibrinogen may also be measured to monitor liver function, since the liver produces this protein, or as part of an inflammation workup together with markers like CRP and ESR. In some cases, it is tracked during pregnancy or critical illness to watch for changes in clotting balance.

Fibrinogen results are usually reported in mg/dL and compared with a standard reference range for adults, though the exact cutoffs can vary somewhat between laboratories and testing methods. The table below shows a commonly used adult range; always compare results with the range listed on your own lab report, since methods and units can differ.

Higher-than-usual fibrinogen levels are most often linked to inflammation, since fibrinogen behaves as an acute-phase reactant and tends to rise whenever the body is fighting infection, healing from injury, or recovering from recent surgery. Chronic low-grade inflammation, such as that seen with obesity or long-term smoking, can also push fibrinogen levels up over time. Elevated fibrinogen is sometimes noted during pregnancy, since normal hormonal changes increase clotting factors, and it can also rise with estrogen-containing medications like oral contraceptives or hormone therapy. Some autoimmune and inflammatory conditions, kidney disease involving protein loss such as nephrotic syndrome, and certain cancers have been associated with higher fibrinogen. Because fibrinogen is involved in clot formation, persistently high levels have also been studied as a possible marker linked to cardiovascular disease risk, alongside other markers like CRP. A single high result does not necessarily point to a specific condition, and interpretation depends on symptoms, other lab results such as ESR, and overall health history. A healthcare provider can help determine whether a high fibrinogen result needs further evaluation or is simply part of a temporary inflammatory response.

Low fibrinogen levels are less common than high ones and can point to a few different processes. Since the liver produces fibrinogen, advanced liver disease can reduce how much is made and released into the blood. Fibrinogen can also drop when it is used up faster than the body can replace it, such as during disseminated intravascular coagulation (DIC), a serious condition where clotting factors are consumed throughout the body, or after major bleeding, trauma, or large-volume blood transfusion. Rare inherited conditions, called afibrinogenemia or hypofibrinogenemia, involve the body making little or no fibrinogen from birth. Certain medications, severe malnutrition, and some cancer treatments have also been linked to lower fibrinogen levels. Because low fibrinogen can affect the blood's ability to clot normally, unexpected low results are typically followed up with additional testing and a discussion with a healthcare provider about possible causes and next steps.

Fibrinogen is usually interpreted together with other coagulation and inflammation markers rather than on its own. PT/INR and aPTT look at how quickly blood clots overall, while platelet count reflects the cell fragments involved in forming a clot; abnormal fibrinogen combined with changes in these tests can help narrow down possible causes. Because fibrinogen is an acute-phase reactant, it often moves in the same direction as CRP and ESR during inflammation or infection. Lifestyle factors such as smoking, pregnancy, recent surgery, and use of estrogen-containing medications can raise fibrinogen, while liver problems or clotting disorders can lower it. Reference ranges and measurement methods vary between laboratories, so results are best compared against the range on the specific report and reviewed with a healthcare provider who knows your health history.

If your fibrinogen result is outside the typical range, it is best discussed with a healthcare provider who can consider it alongside your symptoms, medical history, and other lab tests. Seek urgent care right away if you notice unusual bleeding, easy bruising, blood in urine or stool, sudden severe headache, or signs of a blood clot such as leg swelling, chest pain, or shortness of breath. Bring related results, such as PT/INR or platelet count, to your appointment for a fuller picture. If you want help understanding a lab report in plain language, you can upload it to MediWing to get an easy-to-read summary and track how your results change over time.